Generation and characterization of avian-derived anti-human CD19 single chain fragment antibodies

Keng Chang Tsai, Chen Wei Chiang, Yan Ni Lo, Fu Ling Chang, Tsai Yu Lin, Chang Yu Chang, Wang Chuan Chen, Yu Ching Lee

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The human cluster of differentiation 19 (CD19) is highly expressed in most leukemia, rendering is a promising therapeutic target. In this study, we generated anti-CD19 single-chain variable fragments (scFv) from immunized chickens by phage display technology. After constructing a scFv antibody library with 2.5 × 108 compositional diversity for panning, one representative scFv clone S2 which can specifically recognize to the CD19 protein was isolated and characterized. The binding reactivity of the scFv S2 to the endogenous CD19 protein of the ARH-77 leukemia cancer cell was verified through flow cytometry and the binding affinity of scFv S2 is 6.9 × 10−8 M determined by the surface plasmon resonance system. Compared with the chicken germline, hyper mutation in the complementarity-determining regions (CDRs) suggested that scFv S2 could be generated through an antigen-driven humoral response. By molecular modeling, the possible CDR configurations of scFv S2 were constructed rationally. Furthermore, the characteristics of chicken antibodies of a protein database were investigated. The findings in this study contribute to antibody development and engineering because they reveal the geometric structures and properties of the CDRs in chicken antibodies.

Original languageEnglish
JournalAnimal Biotechnology
DOIs
Publication statusAccepted/In press - Jan 1 2018

Fingerprint

Complementarity Determining Regions
Single-Chain Antibodies
Immunoglobulin Fragments
Antibodies
Chickens
chickens
antibodies
Proteins
leukemia
Leukemia
Bacteriophages
Molecular modeling
Flow cytometry
Surface plasmon resonance
surface plasmon resonance
Protein Databases
Surface Plasmon Resonance
proteins
Germ-Line Mutation
rendering

Keywords

  • Human cluster of differentiation 19
  • leukemia
  • molecular modeling
  • phage display technology
  • single chain variable fragment

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Animal Science and Zoology

Cite this

Generation and characterization of avian-derived anti-human CD19 single chain fragment antibodies. / Tsai, Keng Chang; Chiang, Chen Wei; Lo, Yan Ni; Chang, Fu Ling; Lin, Tsai Yu; Chang, Chang Yu; Chen, Wang Chuan; Lee, Yu Ching.

In: Animal Biotechnology, 01.01.2018.

Research output: Contribution to journalArticle

Tsai, Keng Chang ; Chiang, Chen Wei ; Lo, Yan Ni ; Chang, Fu Ling ; Lin, Tsai Yu ; Chang, Chang Yu ; Chen, Wang Chuan ; Lee, Yu Ching. / Generation and characterization of avian-derived anti-human CD19 single chain fragment antibodies. In: Animal Biotechnology. 2018.
@article{82601de161c943fc836f8b29d73cf2cb,
title = "Generation and characterization of avian-derived anti-human CD19 single chain fragment antibodies",
abstract = "The human cluster of differentiation 19 (CD19) is highly expressed in most leukemia, rendering is a promising therapeutic target. In this study, we generated anti-CD19 single-chain variable fragments (scFv) from immunized chickens by phage display technology. After constructing a scFv antibody library with 2.5 × 108 compositional diversity for panning, one representative scFv clone S2 which can specifically recognize to the CD19 protein was isolated and characterized. The binding reactivity of the scFv S2 to the endogenous CD19 protein of the ARH-77 leukemia cancer cell was verified through flow cytometry and the binding affinity of scFv S2 is 6.9 × 10−8 M determined by the surface plasmon resonance system. Compared with the chicken germline, hyper mutation in the complementarity-determining regions (CDRs) suggested that scFv S2 could be generated through an antigen-driven humoral response. By molecular modeling, the possible CDR configurations of scFv S2 were constructed rationally. Furthermore, the characteristics of chicken antibodies of a protein database were investigated. The findings in this study contribute to antibody development and engineering because they reveal the geometric structures and properties of the CDRs in chicken antibodies.",
keywords = "Human cluster of differentiation 19, leukemia, molecular modeling, phage display technology, single chain variable fragment, Human cluster of differentiation 19, leukemia, molecular modeling, phage display technology, single chain variable fragment",
author = "Tsai, {Keng Chang} and Chiang, {Chen Wei} and Lo, {Yan Ni} and Chang, {Fu Ling} and Lin, {Tsai Yu} and Chang, {Chang Yu} and Chen, {Wang Chuan} and Lee, {Yu Ching}",
year = "2018",
month = "1",
day = "1",
doi = "10.1080/10495398.2018.1486323",
language = "English",
journal = "Animal Biotechnology",
issn = "1049-5398",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Generation and characterization of avian-derived anti-human CD19 single chain fragment antibodies

AU - Tsai, Keng Chang

AU - Chiang, Chen Wei

AU - Lo, Yan Ni

AU - Chang, Fu Ling

AU - Lin, Tsai Yu

AU - Chang, Chang Yu

AU - Chen, Wang Chuan

AU - Lee, Yu Ching

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The human cluster of differentiation 19 (CD19) is highly expressed in most leukemia, rendering is a promising therapeutic target. In this study, we generated anti-CD19 single-chain variable fragments (scFv) from immunized chickens by phage display technology. After constructing a scFv antibody library with 2.5 × 108 compositional diversity for panning, one representative scFv clone S2 which can specifically recognize to the CD19 protein was isolated and characterized. The binding reactivity of the scFv S2 to the endogenous CD19 protein of the ARH-77 leukemia cancer cell was verified through flow cytometry and the binding affinity of scFv S2 is 6.9 × 10−8 M determined by the surface plasmon resonance system. Compared with the chicken germline, hyper mutation in the complementarity-determining regions (CDRs) suggested that scFv S2 could be generated through an antigen-driven humoral response. By molecular modeling, the possible CDR configurations of scFv S2 were constructed rationally. Furthermore, the characteristics of chicken antibodies of a protein database were investigated. The findings in this study contribute to antibody development and engineering because they reveal the geometric structures and properties of the CDRs in chicken antibodies.

AB - The human cluster of differentiation 19 (CD19) is highly expressed in most leukemia, rendering is a promising therapeutic target. In this study, we generated anti-CD19 single-chain variable fragments (scFv) from immunized chickens by phage display technology. After constructing a scFv antibody library with 2.5 × 108 compositional diversity for panning, one representative scFv clone S2 which can specifically recognize to the CD19 protein was isolated and characterized. The binding reactivity of the scFv S2 to the endogenous CD19 protein of the ARH-77 leukemia cancer cell was verified through flow cytometry and the binding affinity of scFv S2 is 6.9 × 10−8 M determined by the surface plasmon resonance system. Compared with the chicken germline, hyper mutation in the complementarity-determining regions (CDRs) suggested that scFv S2 could be generated through an antigen-driven humoral response. By molecular modeling, the possible CDR configurations of scFv S2 were constructed rationally. Furthermore, the characteristics of chicken antibodies of a protein database were investigated. The findings in this study contribute to antibody development and engineering because they reveal the geometric structures and properties of the CDRs in chicken antibodies.

KW - Human cluster of differentiation 19

KW - leukemia

KW - molecular modeling

KW - phage display technology

KW - single chain variable fragment

KW - Human cluster of differentiation 19

KW - leukemia

KW - molecular modeling

KW - phage display technology

KW - single chain variable fragment

UR - http://www.scopus.com/inward/record.url?scp=85053900901&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053900901&partnerID=8YFLogxK

U2 - 10.1080/10495398.2018.1486323

DO - 10.1080/10495398.2018.1486323

M3 - Article

JO - Animal Biotechnology

JF - Animal Biotechnology

SN - 1049-5398

ER -